Matthew Cooper's Insider Trades & SAST Disclosures
Matthew Cooper's most recent trade in Capital One Financial Corp. was a trade of 6,390 Common Stock done . Disclosure was reported to the exchange on March 10, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Matthew Cooper.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Capital One Financial Corp. | Matthew W. Cooper | General Counsel & Corp Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 6,390 | 77,253 (0%) | 0% | 0 | Common Stock | |
| Capital One Financial Corp. | Matthew W. Cooper | General Counsel & Corp Secy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 163.87 per share. | 10 Mar 2025 | 2,882 | 74,371 (0%) | 0% | 163.9 | 472,273 | Common Stock |
| Capital One Financial Corp. | Matthew W. Cooper | General Counsel & Corp Secy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 202.16 per share. | 15 Feb 2025 | 1,735 | 70,863 (0%) | 0% | 202.2 | 350,748 | Common Stock |
| Capital One Financial Corp. | Matthew W. Cooper | General Counsel & Corp Secy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 202.16 per share. | 15 Feb 2025 | 1,390 | 72,598 (0%) | 0% | 202.2 | 281,002 | Common Stock |
| Capital One Financial Corp. | Matthew W. Cooper | General Counsel & Corp Secy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 202.16 per share. | 15 Feb 2025 | 742 | 73,988 (0%) | 0% | 202.2 | 150,003 | Common Stock |
| Capital One Financial Corp. | Matthew W. Cooper | General Counsel & Corp Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 8,001 | 74,730 (0%) | 0% | 0 | Common Stock | |
| Capital One Financial Corp. | Matthew W. Cooper | General Counsel & Corp Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 14,517 | 73,277 (0%) | 0% | 0 | Common Stock | |
| Capital One Financial Corp. | Matthew W. Cooper | General Counsel & Corp Secy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 138.46 per share. | 11 Mar 2024 | 6,548 | 66,729 (0%) | 0% | 138.5 | 906,636 | Common Stock |
| Capital One Financial Corp. | Matthew Cooper W. | General Counsel & Corp Secy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 136.36 per share. | 15 Feb 2024 | 1,518 | 58,760 (0%) | 0% | 136.4 | 206,994 | Common Stock |
| Capital One Financial Corp. | Cooper Matthew W. | General Counsel & Corp Secy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 136.36 per share. | 15 Feb 2024 | 873 | 61,009 (0%) | 0% | 136.4 | 119,042 | Common Stock |
| Capital One Financial Corp. | Cooper Matthew W. | General Counsel & Corp Secy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 136.36 per share. | 15 Feb 2024 | 731 | 60,278 (0%) | 0% | 136.4 | 99,679 | Common Stock |
| Capital One Financial Corp. | Matthew Cooper W. | General Counsel & Corp Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 11,538 | 61,882 (0%) | 0% | 0 | Common Stock | |
| Capital One Financial Corp. | Matthew W. Cooper | General Counsel & Corp Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 15,324 | 57,256 (0%) | 0% | 0 | Common Stock | |
| Capital One Financial Corp. | Matthew W. Cooper | General Counsel & Corp Secy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 108.58 per share. | 01 Mar 2023 | 6,912 | 50,344 (0%) | 0% | 108.6 | 750,505 | Common Stock |
| Capital One Financial Corp. | Matthew W. Cooper | General Counsel & Corp Secy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 114.63 per share. | 15 Feb 2023 | 980 | 43,678 (0%) | 0% | 114.6 | 112,337 | Common Stock |
| Capital One Financial Corp. | Matthew W. Cooper | General Counsel & Corp Secy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 114.63 per share. | 15 Feb 2023 | 874 | 42,804 (0%) | 0% | 114.6 | 100,187 | Common Stock |
| Capital One Financial Corp. | Matthew W. Cooper | General Counsel & Corp Secy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 114.63 per share. | 15 Feb 2023 | 872 | 41,932 (0%) | 0% | 114.6 | 99,957 | Common Stock |
| Capital One Financial Corp. | Matthew W. Cooper | General Counsel & Corp Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 10,770 | 44,658 (0%) | 0% | 0 | Common Stock | |
| Capital One Financial Corp. | Matthew W. Cooper | General Counsel & Corp Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2022 | 17,498 | 41,780 (0%) | 0% | 0 | Common Stock | |
| Capital One Financial Corp. | Matthew W. Cooper | General Counsel & Corp Secy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 130.09 per share. | 11 Mar 2022 | 7,892 | 33,888 (0%) | 0% | 130.1 | 1,026,670 | Common Stock |
| Capital One Financial Corp. | Matthew W. Cooper | General Counsel & Corp Secy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 158.89 per share. | 15 Feb 2022 | 1,309 | 24,282 (0%) | 0% | 158.9 | 207,987 | Common Stock |
| Capital One Financial Corp. | Matthew W. Cooper | General Counsel & Corp Secy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 158.89 per share. | 15 Feb 2022 | 1,150 | 25,591 (0%) | 0% | 158.9 | 182,724 | Common Stock |
| Capital One Financial Corp. | Matthew W. Cooper | General Counsel & Corp Secy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 158.89 per share. | 15 Feb 2022 | 932 | 26,741 (0%) | 0% | 158.9 | 148,085 | Common Stock |
| Capital One Financial Corp. | Matthew W. Cooper | General Counsel & Corp Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 7,277 | 27,673 (0%) | 0% | 0 | Common Stock | |
| Capital One Financial Corp. | Matthew W. Cooper | General Counsel | Sale of securities on an exchange or to another person at price $ 146.82 per share. | 27 Jan 2022 | 6,767 | 20,396 (0%) | 0% | 146.8 | 993,531 | Common Stock |
| Biora Therapeutics Inc | Matthew Cooper | General Manager, Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.47 per share. | 15 Nov 2021 | 700 | 134,039 | - | 3.5 | 2,429 | Common Stock |
| Biora Therapeutics Inc | Matthew Cooper | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.66 per share. | 15 Aug 2021 | 560 | 127,852 | - | 1.7 | 930 | Common Stock |
| Biora Therapeutics Inc | Matthew Cooper | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.36 per share. | 15 May 2021 | 1,400 | 128,412 | - | 2.4 | 3,304 | Common Stock |
| Capital One Financial Corp. | Matthew W. Cooper | General Counsel | Sale of securities on an exchange or to another person at price $ 148.45 per share. | 30 Apr 2021 | 7,703 | 28,463 (0%) | 0% | 148.4 | 1,143,510 | Common Stock |
| Capital One Financial Corp. | Matthew W. Cooper | General Counsel | Sale of securities on an exchange or to another person at price $ 149.18 per share. | 30 Apr 2021 | 1,300 | 27,163 (0%) | 0% | 149.2 | 193,934 | Common Stock |
| Biora Therapeutics Inc | Matthew Cooper | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 168,797 | 168,797 | - | - | Stock Option (Right to Buy) | |
| Biora Therapeutics Inc | Matthew Cooper | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 80,460 | 129,812 | - | 0 | Common Stock | |
| Biora Therapeutics Inc | Matthew Cooper | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2021 | 98,991 | 98,991 | - | - | Stock Option (Right to Buy) | |
| Capital One Financial Corp. | Matthew W. Cooper | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 3,402 | 37,701 (0%) | 0% | 0 | Common Stock | |
| Capital One Financial Corp. | Matthew W. Cooper | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 132.10 per share. | 11 Mar 2021 | 1,535 | 36,166 (0%) | 0% | 132.1 | 202,774 | Common Stock |
| Biora Therapeutics Inc | Matthew Cooper | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.05 per share. | 04 Mar 2021 | 1,609 | 49,352 | - | 4.0 | 6,516 | Common Stock |
| Capital One Financial Corp. | Matthew W. Cooper | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2021 | 1,312 | 38,651 (0%) | 0% | 0 | Common Stock | |
| Capital One Financial Corp. | Matthew W. Cooper | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2021 | 1,312 | 0 | - | - | 2018 Restricted Stock Units | |
| Capital One Financial Corp. | Matthew W. Cooper | General Counsel | Sale or transfer of securities back to the company at price $ 109.60 per share. | 15 Feb 2021 | 1,312 | 37,339 (0%) | 0% | 109.6 | 143,795 | Common Stock |
| Capital One Financial Corp. | Matthew W. Cooper | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 117.75 per share. | 15 Feb 2021 | 1,259 | 34,299 (0%) | 0% | 117.7 | 148,247 | Common Stock |
| Capital One Financial Corp. | Matthew W. Cooper | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 117.75 per share. | 15 Feb 2021 | 934 | 35,558 (0%) | 0% | 117.8 | 109,979 | Common Stock |
| Capital One Financial Corp. | Matthew W. Cooper | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 117.75 per share. | 15 Feb 2021 | 847 | 36,492 (0%) | 0% | 117.7 | 99,734 | Common Stock |
| Biora Therapeutics Inc | Matthew Cooper | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.60 per share. | 15 Feb 2021 | 662 | 50,961 | - | 5.6 | 3,707 | Common Stock |
| Capital One Financial Corp. | Matthew W. Cooper | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2021 | 8,703 | 37,339 (0%) | 0% | 0 | Common Stock | |
| Biora Therapeutics Inc | Matthew Cooper | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.32 per share. | 19 Dec 2020 | 1,805 | 51,623 | - | 6.3 | 11,408 | Common Stock |
| Biora Therapeutics Inc | Matthew Cooper | Chief Scientific Officer | Purchase of securities on an exchange or from another person at price $ 8.55 per share. | 02 Sep 2020 | 9,151 | 53,428 | - | 8.5 | 78,241 | Common Stock |
| Biora Therapeutics Inc | Matthew Cooper | Chief Scientific Officer | Purchase of securities on an exchange or from another person at price $ 8.55 per share. | 02 Sep 2020 | 99 | 44,277 | - | 8.5 | 846 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges